SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 178.00K | -- | 11.94M | 3.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 178.00K | -- | 11.94M | 3.45M |
| Cost of Revenue | 10.50M | 12.73M | 12.98M | 15.58M | 19.63M |
| Gross Profit | -10.50M | -12.55M | -12.98M | -3.64M | -16.18M |
| SG&A Expenses | 5.61M | 4.56M | 5.28M | 5.53M | 6.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.12M | 17.29M | 18.26M | 21.11M | 26.55M |
| Operating Income | -16.12M | -17.11M | -18.26M | -9.17M | -23.10M |
| Income Before Tax | -23.64M | -16.77M | -17.69M | -13.55M | -22.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.64M | -16.77M | -17.69M | -13.55M | -22.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.64M | -16.77M | -17.69M | -13.55M | -22.64M |
| EBIT | -16.12M | -17.11M | -18.26M | -9.17M | -23.10M |
| EBITDA | -15.49M | -16.91M | -18.04M | -8.50M | -22.82M |
| EPS Basic | -0.80 | -0.57 | -0.60 | -0.46 | -0.77 |
| Normalized Basic EPS | -0.34 | -0.36 | -0.37 | -0.18 | -0.48 |
| EPS Diluted | -0.80 | -0.57 | -0.60 | -0.46 | -0.77 |
| Normalized Diluted EPS | -0.34 | -0.36 | -0.37 | -0.18 | -0.48 |
| Average Basic Shares Outstanding | 29.49M | 29.49M | 29.49M | 29.44M | 29.28M |
| Average Diluted Shares Outstanding | 29.49M | 29.49M | 29.49M | 29.44M | 29.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
